Analyze Diet
microPublication biology2025; 2025; doi: 10.17912/micropub.biology.001399

Biochemical characterization of collagen I in Warmblood Fragile Foal Syndrome horse lysyl hydroxylase 1 mutation.

Abstract: Mutations in the collagen-modifying enzyme lysyl hydroxylase 1 (LH1) cause Warmblood Fragile Foal Syndrome (WFFS) in horses. We investigated the impact of this mutation on collagen structure and function. Our results show that LH1 deficiency leads to reduced lysine hydroxylation, altered collagen fibril organization, and tissue abnormalities resembling human Ehlers-Danlos syndrome. These findings highlight the critical role of LH1 in collagen biosynthesis and provide insights into the pathogenesis of WFFS.
Publication Date: 2025-01-03 PubMed ID: 39839713PubMed Central: PMC11749069DOI: 10.17912/micropub.biology.001399Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research investigates the effects of a mutation in the enzyme lysyl hydroxylase 1 (LH1) that leads to Warmblood Fragile Foal Syndrome (WFFS) in horses, finding that LH1 deficiency results in decreased lysine hydroxylation, irregular collagen fibril structure, and tissue anomalies akin to the human condition Ehlers-Danlos syndrome.

Investigation into the Impact of LH1 Mutation

  • This study dives into mutations in the enzyme lysyl hydroxylase 1 (LH1) that lead to Warmblood Fragile Foal Syndrome (WFFS) in horses. The researchers aimed to understand the extent and nature of these mutations’ influence on the structure and function of collagen, a primary component of connective tissues.

LH1 Deficiency and Reduced Lysine Hydroxylation

  • The scientists found that a deficiency in LH1 results in a decrease in lysine hydroxylation – a crucial biochemical process that aids in the formation and stabilization of collagen. This reduced process could likely lead to weaker connective tissues, thus causing the physical symptoms observed in horses with WFFS.

Impact on Collagen Fibril Organization

  • In addition to the reduction of lysine hydroxylation, the LH1 mutation also impacts the organization of collagen fibrils. Normally, collagen fibrils have a regulated, uniform structure that helps contribute to their strength. However, this study showed that the LH1 mutation leads to an altered, likely irregular, collagen fibril organization, which may explain the fragility and weakness of the tissues in WFFS horses.

Link to Human Ehlers-Danlos Syndrome

  • Interestingly, the researchers drew parallels between the tissue abnormalities observed in horses with WFFS due to LH1 mutation and those seen in humans suffering from Ehlers-Danlos syndrome. The similar disorder in collagen biosynthesis and fibril formation in both conditions provides valuable insights into the pathogenesis of such connective tissue diseases not just in horses, but potentially also in humans.

Significance of the Study

  • By unpacking how the mutation in the LH1 enzyme impacts collagen biosynthesis and subsequently leads to WFFS, this research delivers crucial knowledge about the pathogenesis of the syndrome. It also underscores the vital role of LH1 in the production of collagen. Such findings pave the way for future studies and potential therapeutic strategies aimed at managing such conditions, both in veterinary and human medicine.

Cite This Article

APA
Ishikawa Y, Tufa SF, Keene DR, Bächinger HP, Winand NJ. (2025). Biochemical characterization of collagen I in Warmblood Fragile Foal Syndrome horse lysyl hydroxylase 1 mutation. MicroPubl Biol, 2025. https://doi.org/10.17912/micropub.biology.001399

Publication

ISSN: 2578-9430
NlmUniqueID: 101759238
Country: United States
Language: English
Volume: 2025

Researcher Affiliations

Ishikawa, Yoshihiro
  • Department of Ophthalmology, University of California, San Francisco, San Francisco, California, United States.
Tufa, Sara F
  • Micro-Imaging Center, Shriners Children's, Portland, Oregon, United States.
Keene, Douglas R
  • Micro-Imaging Center, Shriners Children's, Portland, Oregon, United States.
Bächinger, Hans Peter
  • Department of Biochemistry and Molecular Biology, Oregon Health & Science University, Portland, Oregon, United States.
Winand, Nena J
  • Department of Molecular Medicine, College of Veterinary Medicine, Cornell University, Ithaca, New York, United States.

Conflict of Interest Statement

The authors declare that there are no conflicts of interest present.

References

This article includes 37 references